Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Certara
Certara
Activities:
Research & Development
Digital
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Regulatory
Certara replaces in-vivo clinical studies for complex generic drug
Virtual bioequivalent was successfully used for FDA abbreviated new drug application (ANDA) approval
Research & Development
Dr William F Feehery is new Certara CEO
Effective 3 June, Dr William F Feehery will take over the model-informed drug development services company
Drug Delivery
Model-informed precision dosing gains scientific support
Certara has published four new papers to provide the necessary evidence to bring model-informed precision dosing to clinics
Research & Development
Certara upgrades drug development Simcyp Simulator
Company launches version 18 of the popular software behind more than 90% FDA-approved drugs
Manufacturing
Certara publishes new report investigating success factors for outcomes-based contracting
Analytica Laser and BaseCase introduce Certara evidence and access solutions for US managed markets
Research & Development
US FDA awards Certara’s Simcyp Division two new dermal virtual bioequivalence grants
New grants support FDA’s GDUFA priorities of expanding bioequivalence methods for topical dermatological products and improving PBPK models of drug absorption via complex delivery routes
Digital
Certara launches BaseCase Portal
The portal will enable life science companies to deliver therapeutic decision-making apps to healthcare professionals at the point of care to individualise patient treatment by making precision-dosing recommendations
Subscribe now